MRI Has a Role to Play After Negative Prostate Biopsy

Share this content:
MRI Has a Role to Play After Negative Prostate Biopsy
MRI Has a Role to Play After Negative Prostate Biopsy

THURSDAY, Dec. 15, 2016 (HealthDay News) -- Magnetic resonance imaging (MRI) and MRI-targeted biopsies have a role in the diagnosis and treatment of patients with a prior negative prostate biopsy, according to a review published in the December issue of The Journal of Urology.

Andrew B. Rosenkrantz, M.D., from the NYU Langone Medical Center in New York City, and colleagues conducted a literature review and formed consensus statements relating to the role of prostate MRI and MRI-targeted biopsy in patients with a negative biopsy.

The authors note that there are various options for men with a prior negative biopsy. Prostate MRI and subsequent MRI-targeted cores appear to facilitate detection of clinically significant disease over repeat biopsy if a biopsy is recommended. For any patient with a prior negative biopsy who has persistent clinical suspicion for prostate cancer and who is under evaluation for possible repeat biopsy, high-quality prostate MRI should be strongly considered. The decision to perform imaging in this setting should account for results of other biomarkers and cost of the examination. To achieve optimal results, experience of the reporting radiologist and biopsy operator are required.

"If a repeat biopsy is deferred on the basis of magnetic resonance imaging findings, then continued clinical and laboratory follow-up is advised and consideration should be given to incorporating repeat magnetic resonance imaging in this diagnostic surveillance regimen," the authors write.

Several authors disclosed financial ties to the medical publishing, biotechnology, and medical device industries.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »